01/26/2016 - 2:13pm

The Pharmacy Benefit Management Institute released its report, “Pharmacy Trends in Accountable Care Organizations,” giving an overview of the state of ACOs. 

01/26/2016 - 12:35pm

Drug Channels' Adam Fein, CEO, after combing through the 658 pages released last week by the Centers for Medicare & Medicaid Services regarding the final rule governing Average Manufacturer Price under the Patient Protection and Affordable Care Act, outlined the seven ways this new rule will impact pharmacy. "Savor all of the bureaucratese for yourself in the oh-so-brief 658-page rule, known to the cool kids as CMS-2345-FC," Fein writes. His observations outline potential impacts including prescription reimbursement, pharmacy profits and channel strategies. (Read through to the end, and Fein provides  a bonus five observations.) (Drug Channels)

01/26/2016 - 12:33pm

Two Hy-Vee subsidiaries received full specialty pharmacy accreditation from URAC. 

01/26/2016 - 11:37am

Crain’s New York Business is reporting that New York Gov. Andrew Cuomo is facing opposition from pharmacies on his proposed efforts to curb Medicaid spending for specialty drugs. (Crain's)

01/26/2016 - 10:52am

Tresiba is designed to last at least 42 hours after eight once-a-day injections, and can allow patients to dose themselves at a time that accommodates their schedule. 

01/25/2016 - 12:50pm
From 2005 to 2013, Perrigo had been the distributor of all Retin-A generic products, which treat acne. 
01/25/2016 - 12:31pm

The new indication comes just a few months after the FDA approved Botox to treat upper limb spasticity in two thumb muscles and six years after it was approved to treat upper limb spasticity in the elbow, wrist and fingers. 

 
01/25/2016 - 11:41am

Rexall is the first retail pharmacy in Canada to offer OneStopMeds to patients in multiple provinces.

01/25/2016 - 10:26am

Based on industry quality benchmarks, URAC reviewed and certified Walgreens Specialty Pharmacy centralized services based on clinical credentials, operating processes and patient management results.